April 18, 2011
/PRNewswire/ -- Tibet Pharmaceuticals, Inc. (NASDAQ: TBET), an emerging specialty pharmaceutical company engaged in the development, manufacturing and marketing of traditional Tibetan medicine in
, announces the availability of an updated online Investor Fact Sheet.
"As part of our mission to keep investors informed with the latest developments at the company, we are pleased to release our updated fact sheet," said
, Chief Executive Officer at Tibet Pharmaceuticals. "As demonstrated by our recently announced fully-audited financial results, fiscal 2010 was a tremendous year for our company, having grown revenue 41% to
and net income 42% to
, compared to fiscal 2009. In light of Tibet Pharmaceuticals' solid results, the traditional Tibetan medicine market represents an extremely fragmented business, with no clear leaders and plenty of room for growth through consolidation. This presents a tremendous opportunity for Tibet Pharmaceuticals and we plan to take advantage of this through potential accretive acquisitions in 2011."
"We look forward to increasing communication with the investor community over the next several weeks and on a more proactive basis going forward," continued Mr. Guo. "We remain committed to the highest levels of compliance in the US capital markets and we intend to provide updates on our business opportunities and future growth initiatives as we strive to improve our revenues, earnings and, ultimately, create long term value for our shareholders."
The Investor Fact Sheet provides a clear overview of Tibet Pharmaceuticals' business model and growth potential in
's traditional Tibetan medicine market, and is a great resource for both existing shareholders and prospective investors alike.
The fact sheet is available at:
About Tibet Pharmaceuticals, Inc.
Based in Shangri-La County,
, Tibet Pharmaceuticals, Inc. (NASDAQ: TBET) is a is a rapidly growing specialty pharmaceutical company engaged in the research, development, manufacturing and marketing of modernized traditional Tibetan medicines in
. With over 190 full-time employees and national-wide distributors, the company develops both prescription and over-the-counter ("OTC") traditional Tibetan medicines that promote health in human respiratory, digestive, urinary and reproductive systems. Tibet Pharmaceuticals' products are sold throughout
, with a majority of sales concentrated in the southern provinces, most notably the
, where the company's 52,000 sq. ft. fully GMP-certified manufacturing facilities are located. The access to key raw materials is not generally available outside the province and provides a significant advantage for Tibet Pharmaceuticals.
For more information on Tibet Pharmaceuticals, please visit: